Health & Biotech ScoPo’s Powerplays: ASX health stocks rattling the tin, Telix shares soar ~26% on positive quarterly results October 21, 2022 Pharmaxis completes $10 million capital raise, announces positive interim results for Phase II cancer trial Telix price soars on strong… Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities? October 21, 2022 We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO… Opyl’s TrialKey achieves major milestone with potential to improve clinical trial success rates October 21, 2022 Special Report: Opyl has reached a major milestone with its latest software solution TrialKey that offers enormous commercial potential for… Vida Ventures MD says it’s a rosy outlook for biotech investment in Australia in the long run October 21, 2022 The AusBiotech investment conference kicks off next week in WA and Vida Ventures says venture capital is key for growing… Wellnex Life raises ~$6 million, sets sights on medicinal cannabis market October 20, 2022 Special Report: Wellnex Life is cashed up after a successful share purchase plan and private placement, as it moves to… ASX Biotech Stocks: Fitbit wants to sell your data to doctors and Wellnex eyes OTC medicinal cannabis product October 20, 2022 Fitbit launches new service for doctors to access your data and Wellnex Life raises $2.8m to progress its OTC medicinal… Phase III Trials: These ASX health stocks are on the pivotal home stretch October 20, 2022 Welcome back to part 4 of our Clinical Trials 101 series. In the first of our series we looked at what… Alzheimer’s drug no longer a moonshot as race heats up, ASX-listed Actinogen in the running October 19, 2022 Drugs focusing on Alzheimer’s Disease (AD) have become one of the hottest things in biotech right now. Actinogen is leading… Latest clinical trials back NGS global expansion and show Healthy Heights is growing kids the right way October 19, 2022 Special Report: The CEO of Aussie-listed Nutritional Growth Solutions says she’s delighted with the ‘significant’ positive results from the Aussie-listed… ASX Biotech Stocks: A big red kidney dialysis bus and Recce reduces SARS-CoV-2 in hamsters October 18, 2022 The big red kidney bus has hit the road to provide mobile dialysis in NSW Recce Pharma says R327 can… Next» « Previous